| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Sep 11, 2025 | Sep 11, 2025 | Rapport Therapeutics, Inc. | Director | Buy | 95.0 | +3,500 | 58.33% | ✗ | $79.1K |
| Mar 12, 2025 | Mar 13, 2025 | Rapport Therapeutics, Inc. | Director | Buy | 95.0 | +6,000 | 100.00% | ✗ | $61.2K |